Quarterly report pursuant to Section 13 or 15(d)

Equity (Details Narrative)

v3.10.0.1
Equity (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Apr. 11, 2017
Mar. 30, 2017
Jan. 13, 2017
Jun. 08, 2016
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2016
Fair value of shares based on share price on date of grant         $ 5,374       $ 15,784    
Administrative expense         819,565     $ 558,293 2,440,023 $ 2,298,099  
Deferred compensation         $ 8,788       8,788   $ 24,572
Number of common shares     1,789,500                
Issuance of common stock     $ 1,652,994           $ 1,652,994    
Number of warrant issued during period         833,500       833,500    
Warrant exercise price         $ 1.50       $ 1.50    
Restricted Stock [Member]                      
Issuance of common stock $ 18,000                    
Number of warrant issued during period           37,500          
Warrant exercise price           $ 1.50          
Proceeds from issuance of warrants           $ 56,250     $ 5,455    
Number of shares issued for services 10,000                    
Public Offering [Member]                      
Number of warrant issued during period         61,250   163,300   61,250    
Warrant exercise price         $ 1.20   $ 1.50   $ 1.20    
Warrant term                 5 years    
Proceeds from issuance of warrants             $ 244,950        
Private Placement [Member]                      
Number of warrant issued during period         796,620       796,620    
Warrant exercise price         $ 1.96       $ 1.96    
Warrant term                 5 years    
Unregistered shares of common stock   1,448,400                  
Proceeds from unregistered shares   $ 1,760,317                  
Officer [Member]                      
Number of restricted common stock shares issued during the period       27,500              
Stock options vested rights description       These shares vest 1/3 immediately on the date of the grant and the remaining 2/3 vests equally on March 1, 2017 and March 1, 2018.              
Fair value of shares based on share price on date of grant       $ 54,725